CAJ | 학술논문

MTS1/p16基因的突变和缺失在人类多种肿瘤组织中广泛存在.近年来的研究发现p16在胆管癌的形成及发展中发挥着重要作用,在胆管癌相关疾病中也普遍出现p16的异常表达,表明p16与胆管癌关系密切.目前胆管癌的早期诊断率尚低.p16有可能成为一个具有高诊断价值的定性、定量肿瘤标记物,并且为一些新的治疗方法如靶向治疗技术提供机会,实现早期诊断早期治疗的目的 ,从而提高病人的生存率.
MTS1/p16기인적돌변화결실재인류다충종류조직중엄범존재.근년래적연구발현p16재담관암적형성급발전중발휘착중요작용,재담관암상관질병중야보편출현p16적이상표체,표명p16여담관암관계밀절.목전담관암적조기진단솔상저.p16유가능성위일개구유고진단개치적정성、정량종류표기물,병차위일사신적치료방법여파향치료기술제공궤회,실현조기진단조기치료적목적 ,종이제고병인적생존솔.
The mutations and deletions of the MTS1/p16 gene are widespread in a variety of human tumor tissues.It has been shown that p16 plays an important role in the formation and development of cholangiocarcinoma as research on cholangiocarcinoma has progressed over the years, and it is thought that the abnormal expression of p16 in highly involved in cholangiocarcinoma-related diseases.All these findings indicate that p16 is closely related to cholangiocarcinoma.Early diagnosis of cholangiocarcinoma is still poor, so p16 may be a qualitative and quantitative tumor marker of high diagnostic value and may provide an opportunity for some new therapeutic methods such as targeted therapy.It can achieve the purpose of early diagnosis and early treatment to enhance the survival rate of patients.